JENNIFER YOUNG: Open Payments
NPI 1437521556 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 50 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $700 · 2025 $969
Food & beverage: $969
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $211 |
| Novo Nordisk Inc | 11 | $210 |
| Lilly USA, LLC | 9 | $137 |
| Vanda Pharmaceuticals Inc. | 4 | $123 |
| PFIZER INC. | 4 | $77 |
| Exact Sciences Corporation | 3 | $51 |
| Abbott Laboratories | 2 | $42 |
| ABBVIE INC. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: FANAPT, MOUNJARO, Wegovy, BREZTRI, FARXIGA, AIRSUPRA, Cologuard Collection Kit, Rybelsus.
Industry payments across MI — which companies pay providers there.
